Experts share different views on the U.S. Food and Drug Administration’s (FDA) recent decision to expand its approval of FluMist, allowing the influenza nasal spray to be self-administered for the first time.
Pharmacists can prescribe the nasal vaccine and the spray can also be administered by a caretaker, the FDA said in a statement on Friday.
“For those interested in self- or caregiver-administration, the vaccine manufacturer plans to make the vaccine available through a third-party online pharmacy,” said the FDA.
These people would be screened to see if they are eligible. If they are, a third-party pharmacy will write the prescription and ship the vaccine to the address provided by the individual. People can also find a health care provider to administer it to them….